Advertisement

Psychopharmaka und Psychotherapie

Chapter
  • 32 Downloads

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Balint M (1984) Der Arzt, sein Patient und die Krankheit. Klett Cotta, Stuttgart.Google Scholar
  2. Beck AT, Hollon SD, Young JE et al. (1985) Treatment of depression with cognitive therapy and amitriptyline. Arch Gen Psychiatry 42: 142–148.PubMedCrossRefGoogle Scholar
  3. Beitman BD (1988) Combining pharmacotherapy and psychotherapy: diagnostic considerations. In: Flach F (ed) Psychobiology and psychopharmacology. Norton, New York, pp 60–74.Google Scholar
  4. Bellack AS, Hersen M, Himmelhoch J (1981) Social skills training compared with pharmacotherapy in the treatment of unipolar depression. Am J Psychiatry 138: 1562–1567.PubMedGoogle Scholar
  5. Bender W (1985) Psychotherapie bei psychotischen Patienten. Nervenarzt 56: 465–471.PubMedGoogle Scholar
  6. Blackburn IM, Bishop S, Glen AIM, Whalley LJ, Christie JE (1981) The efficacy of cognitive therapy in depression: a treatment trial using cognitive therapy and pharmacotherapy, each alone and in combination. Br J Psychiatry 139: 181–189.PubMedCrossRefGoogle Scholar
  7. Blackburn IM, Eunson KM, Bishop S (1986) A two-year naturalistic follow-up of depressed patients treated with cognitive therapy, pharmacotherapy and a combination of both. J Affect Disord 10: 67–75.PubMedCrossRefGoogle Scholar
  8. Böker W, Brenner HD (1986) (Hrsg) Bewältigung der Schizophrenie. Huber, Bern.Google Scholar
  9. Bowers WA (1990) Treatment of depressed inpatients. Cognitive therapy plus medication, relaxation plus medication, and medication alone. Br J Psychiatry 156: 73–78.PubMedCrossRefGoogle Scholar
  10. Bozok B, Bühler KE (1988) Wirkfaktoren der Psychotherapie — spezifische und unspezifische Einflüsse. Fortschr Neurol Psychiat 56: 119–132.PubMedCrossRefGoogle Scholar
  11. Cassano GB, Perugi G, McNair DM (1988) Panic disorder: review of the empirical and rational basis of pharmacological treatment. Pharmacopsychiatry 21: 157–165.PubMedCrossRefGoogle Scholar
  12. Conte HR, Plutchik R, Wild KV, Karasu TB (1986) Combined psychotherapy and pharmacotherapy for depression. A systematic analysis of the evidence. Arch Gen Psychiatry 43: 471–479.PubMedCrossRefGoogle Scholar
  13. Covi L, Lipman RS (1987) Cognitive behavioral group psychotherapy combined with imipramine in major depression. Psychopharmacol Bull 23: 173–176.PubMedGoogle Scholar
  14. Covi L, Lipman RS, Derogatis LR, Smith LE, Pattison JH (1974) Drugs and group psychotherapy in neurotic depression. Am J Psychiatry 131: 191–198.PubMedGoogle Scholar
  15. Crown S (1983) Contraindications and dangers of psychotherapy. Br J Psychiatry 143: 436–441.PubMedCrossRefGoogle Scholar
  16. Dahmer H, Dahmer J (1989) Gesprächsführung. Thieme, Stuttgart.Google Scholar
  17. Danckwardt JF (1979) Anmerkung zur Indikation und Kontraindikation für die gleichzeitige Anwendung von psychoanalytischer Psychotherapie und Psychopharmakotherapie. Psyche 33: 528–544.PubMedGoogle Scholar
  18. Danckwardt JF (1980) Psychopharmaka — ein Problem für Psychotherapeuten?. Prax Psychiat Psychosom 25: 99–113.Google Scholar
  19. Dencker SJ, Fasth BG (1986) Combination of psychotherapy and drugs in the treatment of neurosis. A controlled comparison of bromazepam and thioridazine. Acta Psychiatr Scand 74: 569–575.PubMedCrossRefGoogle Scholar
  20. DiMascio A, Weissman MM, Prusoff BA, Neu C, Zwilling M, Klerman GL (1979) Differential symptom reduction by drugs and psychotherapy in acute depression. Arch Gen Psychiatry 36: 1450–1456.PubMedCrossRefGoogle Scholar
  21. Eckman TA, Liberman RP (1989) Verhaltenstherapeutisches Self-Management-Training und Neuroleptika bei Schizophrenic. In: Hand I, Wittchen HU (Hrsg) Verhaltenstherapie in der Medizin. Springer, Berlin Heidelberg New York Tokyo, S 82–96.CrossRefGoogle Scholar
  22. Elkin I, Shea MT, Watkins JT et al. (1989) National Institute of Mental Health treatment of depression collaborative research program. General effectiveness of treatments. Arch Gen Psychiatry 46: 971–982.PubMedCrossRefGoogle Scholar
  23. Engel RR (1986) Gibt es eine psychologisch inerte Behandlung? In: Hippius H, Überla K, Laakmann G, Hasford J (Hrsg) Das Placebo-Problem. Fischer, Stuttgart, S 107–112.Google Scholar
  24. Falloon IFH (1989) Verhaltenstherapeutisch orientierte Familientherapie bei Schizophrenie. In: Hand I, Wittchen HU (Hrsg) Verhaltenstherapie in der Medizin. Springer, Berlin Heidelberg New York Tokyo, S 97–105.CrossRefGoogle Scholar
  25. Falloon IFH, Liberman RP (1983) Interactions between drug and psychosocial therapy in schizophrenia. Schizophr Bull 9: 543–554.PubMedCrossRefGoogle Scholar
  26. Fichter MM (1998) Behandlung bulimischer Eßstörungen mit Antidepressiva. In: Hippius H, Ortner M, Rüther E (Hrsg) Psychiatrische Erkrankungen in der ärztlichen Praxis. Springer, Berlin Heidelberg New York Tokyo, S 71–76.Google Scholar
  27. Flach F (1988) Psychobiology and psychopharmacology. Norton, New York.Google Scholar
  28. Frank JD, Hoehn-Saric B, Imber ST, Liberman B, Stone A (1978) Effective ingredients of successful psychotherapy. Brunner/Mazel, New York.Google Scholar
  29. Freedman AM (1986) Psychopharmacology and psychotherapy in the treatment of anxiety. Curr Psychiatr Ther 23: 101–118.PubMedGoogle Scholar
  30. Friedman AS (1975) Interaction of drug therapy with marital therapy in depressive patients. Arch Gen Psychiatry 32: 619–627.PubMedCrossRefGoogle Scholar
  31. Gaebel W, Linden M (1984) Kombination von Pharmakotherapie und Psychotherapie in der Behandlung depressiver Störungen. In: Baumann U, Berbalk H, Seidenstücker G (Hrsg) Klinische Psychologie. Trends in Forschung und Praxis, Bd 6. Huber, Bern, S 186–210.Google Scholar
  32. Gaus E, Bechter K, Dreyer KH, Merkle W, Rein A (1987) Untersuchungen zur Bedeutung und Rolle von Medikamenten. In: Quint H, Janssen PL (Hrsg) Psychotherapie in der psychosomatischen Medizin. Springer, Berlin Heidelberg New York Tokyo, S 61–66.CrossRefGoogle Scholar
  33. Göth N, Göth J, Weigelin J (1980) Zum Problem der negativen Effekte in der Psychotherapie. Psychiat Neurol Med Psychol 32: 550–556.PubMedGoogle Scholar
  34. Goldstein MJ (1990) Die Forschung über Familien-und Psychopharmakotherapie der Schizophrenie. In: Hinterhuber H, Kulhanek F, Fleischhacker WW (Hrsg) Kombination therapeutischer Strategien bei schizophrenen Erkrankungen. Vieweg, Braunschweig, S 111–130.Google Scholar
  35. Grawe K (1988) Psychotherapeutische Verfahren im wissenschaftlichen Vergleich. Prax Psychother Psychosom 33: 153–167.Google Scholar
  36. Greenhill MH, Gralnick A (eds) (1983) Psychopharmacology and psychotherapy. Free Press, New York.Google Scholar
  37. Haag G, Birbaumer N (1984) Differentielle Psychotherapieindikation bei psychosomatischen Störungen. In: Baumann U, Berbalk H, Seidenstücker G (Hrsg) Klinische Psychologie. Trends in Forschung und Praxis. Huber, Bern, S 248–262.Google Scholar
  38. Heim E (1985) Praxis der Milieutherapie. Springer, Berlin Heidelberg New York Tokyo.CrossRefGoogle Scholar
  39. Helmchen H, Linden M, Rüger U (1982) (Hrsg) Psychotherapie in der Psychiatrie. Springer, Berlin Heidelberg New York Tokyo.Google Scholar
  40. Herink R (1980) The psychotherapy handbook: the A-Z guide to more than 250 different psychotherapies in use today. Merian, New York.Google Scholar
  41. Hessler M, Lamprecht F (1986) Der Effekt stationärer psychoanalytisch orientierter Behandlung auf den unbehandelten Partner. Psychother Med Psychol 36: 173–178.Google Scholar
  42. Hogarty GE, Anderson CM, Reiss DJ et al. (1991) Family psychoeducation, social skills training, and maintenance chemotherapy in aftercare treatment of schizophrenia. Arch Gen Psychiatry 48: 340–347.PubMedCrossRefGoogle Scholar
  43. Karasu TB (1982) Psychotherapy and pharmacotherapy: toward an integrative model. Am J Psychiatry 139: 1102–1113.PubMedGoogle Scholar
  44. Karasu TB (1990) Toward a clinical model of psychotherapy for depression. II. An integrative and selective treatment approach. Am J Psychiatry 147: 269–278.PubMedGoogle Scholar
  45. Kellam SG, Goldberg SC, Schooler WR, Berman A, Schmelzer JC (1977) Ward atmosphere and outcome of treatment of acute schizophrenics. J Psychiatr Res 5: 145–163.CrossRefGoogle Scholar
  46. Kind H (1982) Psychotherapie und Psychotherapeuten. Thieme, Stuttgart.Google Scholar
  47. Klerman GL, DiMascio A, Weissman MM, Prusoff B, Paykel ES (1974) Treatment of depression by drugs and psychotherapy. Am J Psychiatry 131: 186–191.PubMedGoogle Scholar
  48. Kovacs M, Rush AJ, Beck AT, Hollon SD (1981) Depressed outpatients treated with cognitive therapy or pharmacotherapy: a one year follow-up. Arch Gen Psychiatry 38: 33–41.PubMedCrossRefGoogle Scholar
  49. Kraemer S, Sulz SKD, Schmid H, Lässle R (1987) Kognitive Therapie bei Standardversorgung schizophrener Patienten. Nervenarzt 58: 84–90.PubMedGoogle Scholar
  50. Lam DH (1991) Psychosocial family intervention in schizophrenia: a review of empirical studies. Psychol Med 21: 423–441.PubMedCrossRefGoogle Scholar
  51. Lang H (Hrsg) (1990) Wirkfaktoren der Psychotherapie. Springer, Berlin Heidelberg New York Tokyo.Google Scholar
  52. Luborsky L, Singer B, Luborsky L (1975) Comparative studies of psychotherapies: is it true that “everyone has won and all must have prices”?. Arch Gen Psychiatry 32: 995–1008.PubMedCrossRefGoogle Scholar
  53. Luth P (1974) Sprechstunde und stumme Medizin. Über das Patienten-Arzt-Verhältnis. Herder, Frankfurt.Google Scholar
  54. Marks I, O’Sullivan G (1988) Drugs and psychological treatments for agoraphobia/panic and obsessive-compulsive disorders: a review. Br J Psychiatry 153: 650–658.PubMedCrossRefGoogle Scholar
  55. Mavissakalian MR, Michelson L (1986) Two year follow-up of exposure and imipramine treatment of agoraphobia. Am J Psychiatry 143: 1106–1112.PubMedGoogle Scholar
  56. Meerwein F (1986) Das ärztliche Gespräch. Huber, Bern.Google Scholar
  57. Meltzer HY (ed) (1987) Psychopharmacology: the third generation of progress. Raven Press, New York.Google Scholar
  58. Meterissian GB, Bradwejn J (1989) Comparative studies on the efficacy of psychotherapy, pharmacotherapy, and their combination in depression: was adequate pharmacotherapy provided?. J Clin Psychopharmacol 9: 334–339.PubMedCrossRefGoogle Scholar
  59. Miller IW, Norman WH, Keitner GI (1990) Treatment response of high cognitive dysfunction depressed inpatients. Compr Psychiatry 31: 62–71.PubMedCrossRefGoogle Scholar
  60. Mitchell JE, Pyle RL, Eckert ED et al. (1990) A comparison study of antidepressants and structured intensive group psychotherapy in the treatment of bulimia nervosa. Arch Gen Psychiatry 47: 149–157.PubMedCrossRefGoogle Scholar
  61. Möller HJ (1978) Psychagogische Behandlung. Psychother Med Psychol 28: 165–170.Google Scholar
  62. Müller P (1991) Psychotherapie bei schizophrenen Psychosen — historische Entwicklung, Effizienz und gegenwärtig Anerkanntes. Fortschr Neurol Psychiat 59: 277–285.PubMedCrossRefGoogle Scholar
  63. Murphy GE, Simons AD, Wetzel RD, Lustman PJ (1984) Cognitive therapy and pharmacotherapy singly and together in the treatment of depression. Arch Gen Psychiatry 41: 3341.Google Scholar
  64. Patzold U, Krüger H, Angermeyer M (1976) Einfluß nichtpharmakologischer Faktoren auf den Neuroleptikaverbrauch bei stationär-psychiatrischer Akutbehandlung. Psychiat Prax 3: 222–229.Google Scholar
  65. Perrez M (1991) Behandlung und Therapie (Psychotherapie). In: Perrez M, Baumann U (Hrsg) Klinische Psychologie, Bd 2. Huber, Stuttgart, S 99–116.Google Scholar
  66. Perry S (1990) Combining antidepressants and psychotherapy: rationale and strategies. J Clin Psychiatry 51 [Suppl]: 16–20.PubMedGoogle Scholar
  67. Pfeiffer W (1991) Wodurch wird ein Gespräch therapeutisch?. Psychother Psychosom Med Psychol 41: 93–101.PubMedGoogle Scholar
  68. Pietzcker A (1985) Der Einfluß sozialer Faktoren auf den Erfolg einer Psychopharmakotherapie. Psychiat Prax 12: 19–22.Google Scholar
  69. Remschmidt H (1991) Psychotherapie mit Kindern, Jugendlichen und Familien. Dtsch Ärztebl 88: 1362–1369.Google Scholar
  70. Rickels K, Cattell RB, Weise C et al. (1966) Controlled psychopharmacological research in private psychiatric practice. Psychopharmacologia 9: 288–306.PubMedCrossRefGoogle Scholar
  71. Rötzer-Zimmer FT (1986) Kognitive Verhaltenstherapie depressiver Patienten — Entwicklungen und Perspektiven aus der Therapieforschung. In: Heimann H, Gaertner HJ (Hrsg) Das Verhältnis der Psychiatrie zu ihren Nachbardisziplinen. Springer, Berlin Heidelberg New York Tokyo, S 291–301.CrossRefGoogle Scholar
  72. Rounsaville BJ, Klerman L, Weissman MM (1981) Do psychotherapy and pharmacotherapy for depression conflict?. Arch Gen Psychiatry 38: 24–29.PubMedCrossRefGoogle Scholar
  73. Rüger U (1979) Kombinationen von psychiatrischer Pharmakotherapie und Psychotherapie. Nervenarzt 50: 491–500.Google Scholar
  74. Rüger U (1986) Psychodynamische Prozesse während einer Lithium-Langzeitmedikation. In: Müller-Oerlinghausen B, Greil W (Hrsg) Die Lithiumtherapie. Nutzen, Risiken, Alternativen. Springer, Berlin Heidelberg New York Tokyo, S 223–230.CrossRefGoogle Scholar
  75. Rush AJ, Beck AT, Kovacs M, Hollon S (1977) Comparative efficacy of cognitive therapy and pharmacotherapy in the treatment of depressed outpatients. Cogn Ther Res 1: 17–37.CrossRefGoogle Scholar
  76. Rush AJ, Beck AT, Kovacs M, Hollon S (1982) Comparative efficacy of cognitive therapy and pharmacotherapy on hopelessness and self concept. Am J Psychiatry 139: 862–866.PubMedGoogle Scholar
  77. Schicke RK (1976) Sozialpharmakologie. Kohlhammer, Stuttgart.Google Scholar
  78. Schooler NR (1986) The efficacy of antipsychotic drugs and family therapies in the maintenance treatment of schizophrenia. J Clin Psychopharmacol 6: 11–19.CrossRefGoogle Scholar
  79. Schwabe U, Paffrath D (1991) Arzneiverordnungs-Report’ 91. Fischer, Stuttgart.Google Scholar
  80. Shepherd M, Sartorius N (eds) (1989) Non-specific aspects of treatment. Huber, Bern.Google Scholar
  81. Simons AD, Murphy GE, Levine G, Wetzel R (1986) Cognitive therapy and pharmacotherapy for depression. Sustained improvement over one year. Arch Gen Psychiatry 43: 43–48.PubMedCrossRefGoogle Scholar
  82. Smith ML, Glass GV, Miller TI (1980) The benefits of psychotherapy. John Hopkins, Baltimore.Google Scholar
  83. Strotzka H (1982) Psychotherapie und Tiefenpsychologie. Springer, Wien New York.CrossRefGoogle Scholar
  84. Strupp HH, Hadley SW, Gomes-Schwartz B (1978) Psychotherapy for better or worse. The problem of negative effects. Aronson, New York.Google Scholar
  85. Strupp HH, Hadley SW (1979) Specific vs. nonspecific factors in psychotherapy. Arch Gen Psychiatry 36: 1125–1136.PubMedCrossRefGoogle Scholar
  86. Teasdale JD, Fennell MJV, Hibbert GA, Amies PL (1984) Cognitive therapy for major depressive disorder in primary care. Br J Psychiatry 144: 400–406.PubMedCrossRefGoogle Scholar
  87. Telch M, Agras WS, Taylor CB et al. (1985) Imipramine and behavioral treatment for agoraphobia. Behav Res Ther 23: 325–335.PubMedCrossRefGoogle Scholar
  88. Uhlenhuth EH (1983) The benzodiazepines and psychotherapy: controlled studies of combined treatment. In: Costa E (ed) The benzodiazepines: from molecular biology to clinical practice. Raven Press, New York, pp 325–337.Google Scholar
  89. Zerssen D, Möller HJ, Baumann U, Bühringer G (1986) Evaluative Psychotherapieforschung in der Bundesrepublik Deutschland und West-Berlin. Psychother Med Psychol 36: 8–17.Google Scholar
  90. Wardle J (1990) Behaviour therapy and benzodiazepines: allies or antagonists?. Br J Psychiatry 156: 163–168.PubMedCrossRefGoogle Scholar
  91. Watzlawick P, Beavin JH, Jackson DD (1969) Menschliche Kommunikation. Formen, Störungen, Paradoxien. Huber, Bern.Google Scholar
  92. Weissman MM (1978) Psychotherapy and its relevance to the pharmacotherapy of affective disorders: from ideology to evidence. In: Lipton MA, DiMascio A, Killam KF (eds) Psychophar-macology — a generation of progress. Raven Press, New York, pp 1313–1321.Google Scholar
  93. Weissman MM, Jarrett RB, Rush JA (1987) Psychotherapy and its relevance to the pharmacotherapy of major depression: a decade later (1976–1985). In: Meltzer HY (ed) Psychophar-macology: the third generation of progress. Raven Press, New York, pp 1059–1069.Google Scholar
  94. Weissman MM, Klerman GL, Prusoff BA, Sholomskas D, Padian N (1981) Depressed outpatients. Results one year after treatment with drugs and/or interpersonal psychotherapy. Arch Gen Psychiatry 38: 51–55.PubMedCrossRefGoogle Scholar
  95. Wilson PH (1982) Combined pharmacological and behavioral treatment of depression. Behav Res Ther 20: 173–184.PubMedCrossRefGoogle Scholar
  96. Wolberg LR (1967) The technique of psychotherapy. Grune & Stratton, New York.Google Scholar
  97. Zapotoczky HG (1986) Negative Folgen psychotherapeutischer Verfahren. In: Hinterhuber H, Schubert H, Kulhanek F (Hrsg) Seiteneffekte und Störwirkungen der Psychopharmaka. Schattauer, Stuttgart New York, S 115–128.Google Scholar
  98. Zimmer FT (1989) Verhaltenstherapie und Antidepressiva bei der Behandlung von Depressionen. In: Hand I, Wittchen HU (Hrsg) Verhaltenstherapie in der Medizin. Springer, Berlin Heidelberg New York Tokyo, S 62–81.CrossRefGoogle Scholar
  99. Zitrin CM, Klein DF, Woerner M (1980) Treatment of agoraphobia with group exposure in vivo and imipramine. Arch Gen Psychiatry 37: 63–72.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Wien 1992

Authors and Affiliations

  • G. Laux

There are no affiliations available

Personalised recommendations